Paclitaxel liposome with anti–HER-2 drugs as first-line therapy for recurrent/metastatic HER-2–positive breast cancer: a real-world study.

Bibliographic Details
Published in:	Holistic Integrative Oncology Vol. 5; no. 1; pp. 1 - 12
Main Authors:	Yue, Jian, Zhang, Jin, Wang, Shusen, Zhang, Lili, Zeng, Xiaohua, Li, Huiping, Ma, Fei, Hui, Zhouguang
Format:	research tables/charts Journal Article
Published:	Springer Nature 8/11/2026
Online Access:	View this record in EBSCOhost

Internet